Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?

BackgroundPatients with liver cirrhosis have been excluded from randomized clinical trials of oral anticoagulation therapy for stroke prevention in atrial fibrillation. We hypothesized that patients with liver cirrhosis would have a positive net clinical benefit for oral anticoagulation when used fo...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ling Kuo, Tze‐Fan Chao, Chia‐Jen Liu, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Jo‐Nan Liao, Fa‐Po Chung, Tzeng‐Ji Chen, Gregory Y. H. Lip, Shih‐Ann Chen
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2017-11-01
Col·lecció:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Matèries:	atrial fibrillation intracranial hemorrhage ischemic stroke liver cirrhosis
Accés en línia:	https://www.ahajournals.org/doi/10.1161/JAHA.116.005307
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!